Ever Supreme Bio Technology Co (ROCO:6712) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ever Supreme Bio Technology Co EBITDA Margin % Related Terms
Ever Supreme Bio Technology Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ever Supreme Bio Technology Co EBITDA Margin % Chart
ROCO:6712 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Ever Supreme Bio Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ever Supreme Bio Technology Co EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ever Supreme Bio Technology Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ever Supreme Bio Technology Co (ROCO:6712) has a EBITDA Margin % of 45.30% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 14% below median its historical median of 52.66. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #49 out of 943 companies in the Biotechnology industry, placing it in the top 5.2%.
Is Ever Supreme Bio Technology Co's EBITDA Margin % too high?
Ever Supreme Bio Technology Co's current EBITDA Margin % of 45.30% is 14% below median its 10-year median of 52.66. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #49 out of 943 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #49 out of 943 companies for EBITDA Margin %. This places Ever Supreme Bio Technology Co in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ever Supreme Bio Technology Co and its competitors. Ever Supreme Bio Technology Co's current EBITDA Margin % is 45.30%, which is 14% below median its own 10-year median of 52.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$211.52, compared to a current price of NT$147.50 — trading 30.3% below its estimated fair value. The current EBITDA Margin % is 45.30%, which is 14% below median its 10-year median of 52.66. Ever Supreme Bio Technology Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current EBITDA Margin % is 45.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued.
The current stock price of NT$147.50 is trading 30.3% below its estimated GF Value™ of NT$211.52.
GuruFocus considers Ever Supreme Bio Technology Co to be Significantly Undervalued.
Key valuation signals for ROCO:6712:
EBITDA Margin %: 45.30% (14% below median its 10-year median of 52.66)
GF Value™: NT$211.52 vs. price of NT$147.50 (30.3% below fair value)
No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ever Supreme Bio Technology Co Business Description
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
84GF Score
Get the complete analysis for ROCO:6712
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6712 has been successfully added to your 
